ÂÜÀòÂÒÂ×

Dr. Kramer is former Vice President and Head of Discovery for Oncology Therapeutics at Janssen Research & Development, LLC. He was responsible for leading Global Discovery, focusing on aberrant signaling cascades in tumor cells, as well as epigenetic reprogramming and tumor immunology using both small molecule and protein-based large molecule approaches. Dr. Kramer joined Janssen Research & Development from Bristol-Myers Squibb (BMS), where he was VP Drug Discovery and Research site head in Princeton, NJ where he provided scientific leadership and strategic oversight for many preclinical Oncology and Immunology programs/projects that entered development, several of which have gone on to receive regulatory approvals for treating patients with chronic myeloid leukemia, breast cancer and melanoma.